Asynt, a leading supplier of affordable products, consumables and services for chemists in industry and academia, has introduced their Quadracell 4-position high pressure reactor – a new synthetic tool for scientists seeking the convenience of routine parallel pressure chemistry in a compact footprint.
Designed and manufactured in the UK, the robust Quadracell reactor is simple to set up and to operate, with heating and agitation provided by a standard magnetic hotplate stirrer and magnetic flea.
Constructed in durable stainless steel 316, the Quadracell has four cells – each with a reaction volume of 10 mL – that can routinely operate at temperatures up to 250 °C.
For labs using aggressive or caustic media, the Quadracell is optionally available constructed from Hastelloy C276 for enhanced chemical resistance.
Different versions of the Quadracell
Different versions of the Quadracell are available to safely operate up to your chosen maximum working pressure of 50, 100 or 200 Bar. Each Quadracell high pressure reactor is supplied with a pressure release valve, pressure gauge, gas inlet and gas outlet via two stainless steel needle valves.
With a wide range of accessories available, you can tailor the package to suit your exact chemistry and laboratory setup or select a standard Quadracell turn-key solution that’s ready to use right away.
The Quadracell is a new addition to the comprehensive range of single and multi-position high-performance pressure reactors from Asynt. To download a flyer providing a brief overview of the range, visit: Asynt Pressure Reactors
30 years of DiaSys Diagnostic Systems
, /in Featured Articles /by panglobalThis year marks the 30th anniversary of the founding of DiaSys Diagnostics Systems. CLI chatted to Dr Günther Gorka, Chief Executive Officer and Founder, about the company’s story and innovations.
COVID-19: developing quantitative RT-PCR tests to assess new variants and viral loads
, /in Featured Articles /by panglobalAlthough the roll-out of the severe acute respiratory syndrome coronavirus 2 vaccination programme is proving effective at reducing levels of serious COVID-19 and associated deaths, the pandemic is by no means over. CLI caught up with Alina Merz (Senior Product Manager, Bruker Microbiology and Diagnostics) to find out more about why the need for new […]
Anti-Müllerian hormone and fertility assessment
, /in Featured Articles /by panglobalIt is estimated that around 1 in 6 couples have difficulty conceiving, with causes of infertility split equally between male and female factors. Although it is well known that a woman’s fertility declines sharply from the age of 35 onwards, it is perhaps less discussed that infertility also affects women in younger age groups (7% […]
Instrumentation Laboratory, Inova Diagnostics and Biokit transform organizationally and now share Werfen name
, /in Featured Articles /by panglobalWerfen companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, have united under one name and one brand – Werfen. As part of this effort, the company has completed organizational transitions and adopted a new global brand identity, including a new corporate logo.
Hemostatis automation that works on so many levels
, /in Advertenties /by panglobalOlympus to hold first Organoid Conference to support stem cell research
, /in Events, E-News /by panglobalThink Deep, See Deeper
Scientific Presentations
From BIOCHIPs to artificial intelligence – defining new horizons in IFA
, /in Featured Articles /by panglobalEUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. CLI talked to Dr. Panagiotis Grypiotis, Head of Product Management Automation at EUROIMMUN, to find out about the company’s milestones and the newest innovations on the market.
The only glucose meter cleared by the U.S. FDA for use with critically ill patients
, /in Advertenties /by panglobalAsynt introduces new compact 4-position high pressure benchtop reactor
, /in Product News /by panglobalAsynt, a leading supplier of affordable products, consumables and services for chemists in industry and academia, has introduced their Quadracell 4-position high pressure reactor – a new synthetic tool for scientists seeking the convenience of routine parallel pressure chemistry in a compact footprint.
Designed and manufactured in the UK, the robust Quadracell reactor is simple to set up and to operate, with heating and agitation provided by a standard magnetic hotplate stirrer and magnetic flea.
Constructed in durable stainless steel 316, the Quadracell has four cells – each with a reaction volume of 10 mL – that can routinely operate at temperatures up to 250 °C.
For labs using aggressive or caustic media, the Quadracell is optionally available constructed from Hastelloy C276 for enhanced chemical resistance.
Different versions of the Quadracell
Different versions of the Quadracell are available to safely operate up to your chosen maximum working pressure of 50, 100 or 200 Bar. Each Quadracell high pressure reactor is supplied with a pressure release valve, pressure gauge, gas inlet and gas outlet via two stainless steel needle valves.
With a wide range of accessories available, you can tailor the package to suit your exact chemistry and laboratory setup or select a standard Quadracell turn-key solution that’s ready to use right away.
The Quadracell is a new addition to the comprehensive range of single and multi-position high-performance pressure reactors from Asynt. To download a flyer providing a brief overview of the range, visit: Asynt Pressure Reactors
BioGenes and FyoniBio combine scientific expertise, offer single source for pharmacokinetic and immunogenicity analyses
, /in E-News /by panglobalPharmacokinetic and immunogenicity projects can be both diverse and complex, involving work packages from antibody generation and production to the analysis of clinical samples with validated assays.
In an effort to simplify the process, BioGenes and FyoniBio has signed an agreement under wich they will cooperate to provide a single source for these services.
BioGenes, as an expert in antibody production and ELISA setup, takes care of the first steps of the project, while FyoniBio, a specialist in bioassay development and validation for analysis of clinical samples, uses their expertise to transfer the assay to the MSD2 platform for analysing clinical samples under “good clinical and laboratory practice” (GCLP). Specialists at the Berlin-based companies guarantee comprehensive project management.
“We are very pleased that the cooperation with FyoniBio has now officially started,” said Dr. Alexander Knoll, CEO of BioGenes GmbH. “We are convinced that our complete package for high-quality and customized immunological tests for new biological compounds and clinical samples offers an enormous added value for customers.”
“Both companies want to provide the perfect service for each customer. In this respect, as well as regarding scientific excellence in their respective fields, the two companies complement each other very well,” added Dr. Hans Baumeister, Service Division Manager at FyoniBio. “We are looking forward to the first joint projects.”